Submit Deal

SITEONE THERAPEUTICS INC

HQ - San Francisco

Summary

SiteOne Therapeutics is a biopharmaceutical company developing selective ion channel modulators for the treatment of pain, cough, and other conditions.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 79 M

Avg. Deal Size£ 79 M

Market Context

Senior Management

John Mulcahy
President and CEO

Sort

john mulcahy

President and CEO at SITEONE THERAPEUTICS INC

Manager

Deal

£ 79 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy